Powell Lab in the Press
May 19, 2017: Medical Study Helps Brookings Man Beat Cancer
September 16, 2016: NIH Selects Sanford for grant to move cancer research to clinical trials
July 19, 2016: Sanford physician assists in developing new treatment to prevent nausea, vomiting caused by chemotherapy
February 24, 2016: Sanford head, neck cancer clinical trial will aim to activate immune system
August 1, 2014: Sanford clinical trial looks for genetic targets in cancer
May 2018 A group of Sanford oncologists, medical geneticists, and clinical staff led by Dr. Steven Powell published a manuscript in the Journal of Clinical Oncology: Precision Oncology detailing the Genomic Exploration of the Molecular basis of Malignancy in Adults or GEMMA study.This study explored the use of precision oncology in a community oncology program. Through the GEMMA study, a virtual molecular tumor board was created to utilize data from next generation sequencing to inform on treatment delivery strategies integrated as part of Sanford's community oncology program."Delivering precision oncology in a community cancer program: results from a prospective observational study"
May 2018 Steven Powell and David Pearce presented at a symposium on Developments in the Changing Landscape of Molecular Cancer Genetics in Dublin, Ireland hosted by Sanford Health and Hermitage Medical Clinic.
April 2018 Steven Powell was an author on a clinical research paper published in the New England Journal of Medicine as part of the KEYNOTE-189 phase 3 clinical trial. They found that the addition of pembrolizumab to standard chemotherapy increased both survival and progression-free survival in patients with non-small cell lung cancer. “Pembrolizumab plus chemotherapy in metastatic non-small-cell lung cancer”
February 2018 Steven Powell was recognized by JCO Precision Oncology for his time and dedication as a reviewer. He was among the top three reviews for JCO Precision Oncology in 2017 when taking into account the number of reviews completed, timeliness, and quality of reviews.
February 2018 Dr. Steven Powell attended the Multidisciplinary Head and Neck Cancer Symposium in Scottsdale, AZ. This symposium highlights breakthroughs in head and neck cancer care. The Sanford Health MISO study was highlighted in the Immunotherapy Advances in Head and Neck Cancer Session, and the Sanford team was recognized as leaders in this field.
June 2017 Dr. Steven Powell presented his current research findings at the annual meeting for the American Society for Clinical Oncology (ASCO). Dr. Powell shared safety results of an immunotherapy clinical trial for head and neck cancer. "Safety of pembrolizumab with chemo radiation in locally advanced squamous cell carcinoma of the head and neck."
June 2017 Dr. Steven Powell co-authored a research article published in The Oncologist that identified commonly altered genes in olfactory neuroblastomas which could serve as therapeutic targets. "Comprehensive genomic profiling of esthesioneuroblastoma reveals additional treatment options."
May 2017 Dr. Steven Powell co-authored a phase II clinical study in the Journal of Clinical Oncology investigating the efficacy of Pembrolizumab in patients with recurrent/metastatic head and neck cancer. <"Pembrolizumab for platinum- and cetuximab-refractory head and neck cancer: results from a single-arm, phase II study".
April 2017 Dr. Powell published an article in Oncology Issues highlighting increased cancer patient options at Sanford Health due to improved access to immunotherapy clinical trials. Oncology Issues is published by the Association of Community Cancer Centers (ACCC) and this article was a tribute to the Sanford Cancer Center as the winner of the 2016 ACCC Innovator Award. "Advancing immuno-onoclogy in the community setting."
March 2017 Steven Powell, MD, along with Jill Weimer, PhD, presented to participants of the Leadership Sioux Falls course, organized by the Sioux Falls Area Chamber of Commerce. This program fosters the development of leadership in the greater Sioux Falls community. Dr. Powell spoke on the various oncology clinical trials facilitated through Sanford's clinical research team.
March 2017 Dr. Steven Powell and Dr. Jonathan Bleeker were featured in a Wall Street Journal Article.The article addressed how genetic testing provides specific therapy for patients, and recognized Sanford Health as an innovative healthcare facility that provides cancer therapies that many rural facilities cannot.
February 2017 Dr. Steven Powell was featured on KSOO-A Better You where he discussed a few lung cancer trials. https://soundcloud.com/sanford-health